Research programme: long-acting injectable therapies - Medincell/AbbVie
Latest Information Update: 19 Apr 2024
At a glance
- Originator MedinCell S.A.
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified